GlassScriptPhysician profile
Priya Shah
NPI 1730566142
$930.19
in general payments reported to CMS, 2019-2025
16 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.79 · 2022: $203 · 2023: $111 · 2024: $37.91 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $673.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $273.11 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Madrigal Pharmaceuticals | $147.49 | 2025 | Rezdiffra |
| Exact Sciences Corporation | $110.75 | 2023-2025 | Cologuard Collection Kit |
| Viiv Healthcare Company | $91.89 | 2025 | Dovato |
| Pfizer INC. | $62.06 | 2023-2025 | |
| Globus Medical, INC. | $59.73 | 2025 | Senza |
| Gilead Sciences, INC. | $22.35 | 2025 | |
| Dexcom, INC. | $22.23 | 2025 | Dexcom G6 Transmitter |
| Napo Pharmaceuticals INC | $21.71 | 2025 | Mytesi |
| Janssen Pharmaceuticals, INC | $21.02 | 2019 | |
| Glaxosmithkline, LLC. | $19.97 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $18.74 | 2019 | |
| Azurity Pharmaceuticals, INC. | $17.70 | 2025 | Alvesco |
| Abbvie INC. | $14.48 | 2023 | Lumigan |
| Merck Sharp & Dohme LLC | $14.03 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolder Surgical, LLC | $12.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priya Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.